2021 annual financial data
Travere Therapeutics 2021 Operating income
Direct answer
Operating income was -199,425,000 USD.
Operating income was -199,425,000 USD and net income was -180,091,000 USD.
Operating cash flow was -14,792,000 USD.
Get free Travere Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 131,836,000 USD
- Operating income
- -199,425,000 USD
- Net income
- -180,091,000 USD
- Operating cash flow
- -14,792,000 USD